CELLDEX THERAPEUTICS INC NEW COM NEW is a security (CUSIP 15117B202) tracked across SEC portfolio filings. 240 institutional managers reported $2.3B on Form 13F as of 2026-06-30; 24 registered fund positions totaling $277.3M via N-PORT as of 2026-05-31.
Showing 15 of 240 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $271.5M | 8,560,476 |
| Kynam Capital Management, LP | PRINCETON, NJ | $185.3M | 5,840,567 |
| BlackRock, Inc. | New York, NY | $170.3M | 5,369,885 |
| FMR LLC | BOSTON, MA | $118.9M | 3,749,048 |
| VANGUARD GROUP INC | Valley Forge, PA | $109.4M | 4,027,407 |
| Point72 Asset Management, L.P. | Stamford, CT | $102.5M | 3,229,939 |
| STATE STREET CORP | BOSTON, MA | $88.9M | 2,804,168 |
| COMMODORE CAPITAL LP | NEW YORK, NY | $85.5M | 2,696,616 |
| Eversept Partners, LP | NEW YORK, NY | $56.7M | 1,788,016 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $53.6M | 1,688,074 |
| BRAIDWELL LP | STAMFORD, CT | $43.0M | 1,356,082 |
| Deep Track Capital, LP | GREENWICH, CT | $40.7M | 1,283,979 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $39.8M | 1,253,532 |
| Vestal Point Capital, LP | NEW YORK, NY | $38.8M | 1,224,165 |
| Bellevue Group AG | Kuesnacht, V8 | $38.1M | 1,200,000 |
Showing 15 of 24 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD HEALTH CARE FUND | VANGUARD SPECIALIZED FUNDS | $140.7M | 38.17% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $43.7M | 20.07% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $23.6M | 2.89% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $16.9M | 13.25% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $13.4M | 12.30% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $12.2M | 6.97% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $5.6M | 7.49% |
| HARTFORD SMALL CAP GROWTH HLS FUND | HARTFORD HLS SERIES FUND II INC | $4.0M | 51.83% |
| TIFF MULTI-ASSET FUND | TIFF Investment Program | $3.7M | 26.42% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $3.4M | 7.08% |
| HARTFORD SMALL COMPANY HLS FUND | HARTFORD SERIES FUND INC | $2.6M | 67.21% |
| VANGUARD STRATEGIC EQUITY FUND | VANGUARD HORIZON FUNDS | $2.3M | 2.28% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $1.2M | 0.21% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $965K | 0.32% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $838K | 12.65% |